The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccination
Authors
- H. Maatz
- E.L. Lindberg
- E. Adami
- N. López-Anguita
- A. Perdomo-Sabogal
- L. Cócera Ortega
- G. Patone
- D. Reichart
- A. Myronova
- S. Schmidt
- A. Elsanhoury
- O. Klein
- U. Kühl
- E. Wyler
- M. Landthaler
- S. Yousefian
- S. Haas
- F. Kurth
- S.A. Teichmann
- G.Y. Oudit
- H. Milting
- M. Noseda
- J.G. Seidman
- C.E. Seidman
- B. Heidecker
- L.E. Sander
- B. Sawitzki
- K. Klingel
- P. Doeblin
- S. Kelle
- S. Van Linthout
- N. Hubner
- C. Tschöpe
Journal
- Nature Cardiovascular Research
Citation
- Nat Cardiovasc Res 4 (3): 330-345
Abstract
Myocarditis, characterized by inflammatory cell infiltration, can have multiple etiologies, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or, rarely, mRNA-based coronavirus disease 2019 (COVID-19) vaccination. The underlying cellular and molecular mechanisms remain poorly understood. In this study, we performed single-nucleus RNA sequencing on left ventricular endomyocardial biopsies from patients with myocarditis unrelated to COVID-19 (Non-COVID-19), after SARS-CoV-2 infection (Post-COVID-19) and after COVID-19 vaccination (Post-Vaccination). We identified distinct cytokine expression patterns, with interferon-γ playing a key role in Post-COVID-19, and upregulated IL16 and IL18 expression serving as a hallmark of Post-Vaccination myocarditis. Although myeloid responses were similar across all groups, the Post-Vaccination group showed a higher proportion of CD4(+) T cells, and the Post-COVID-19 group exhibited an expansion of cytotoxic CD8(+) T and natural killer cells. Endothelial cells showed gene expression changes indicative of vascular barrier dysfunction in the Post-COVID-19 group and ongoing angiogenesis across all groups. These findings highlight shared and distinct mechanisms driving myocarditis in patients with and without a history of SARS-CoV-2 infection or vaccination.